These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7454434)

  • 1. Pulmonary nonspecific defense mechanisms in cystic fibrosis. I. Phagocytic capacity of alveolar macrophages and neutrophils.
    Cassino RJ; Sordelli DO; Macri CN; Kohan M; Dillon MH; Pivetta OH
    Pediatr Res; 1980 Nov; 14(11):1212-5. PubMed ID: 7454434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced iC3b-mediated phagocytotic capacity of pulmonary neutrophils in cystic fibrosis.
    Morris MR; Doull IJ; Dewitt S; Hallett MB
    Clin Exp Immunol; 2005 Oct; 142(1):68-75. PubMed ID: 16178858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructure and function of alveolar macrophages from cystic fibrosis patients.
    Thomassen MJ; Demko CA; Wood RE; Tandler B; Dearborn DG; Boxerbaum B; Kuchenbrod PJ
    Pediatr Res; 1980 May; 14(5):715-21. PubMed ID: 6770330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic aspects of surface infections in the lung.
    Piedra P; Ogra PL
    J Pediatr; 1986 May; 108(5 Pt 2):817-23. PubMed ID: 3084749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phagocytosis of Candida albicans by alveolar macrophages from patients with cystic fibrosis.
    Sordelli DO; Cassino RJ; Macri CN; Kohan M; Dillon MH; Pivetta OH
    Clin Immunol Immunopathol; 1982 Feb; 22(2):153-8. PubMed ID: 7049458
    [No Abstract]   [Full Text] [Related]  

  • 6. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion.
    Hornick DB; Fick RB
    J Clin Invest; 1990 Oct; 86(4):1285-92. PubMed ID: 2120286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung defense against infection.
    Quie PG
    J Pediatr; 1986 May; 108(5 Pt 2):813-6. PubMed ID: 3701533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease.
    Koller B; Kappler M; Latzin P; Gaggar A; Schreiner M; Takyar S; Kormann M; Kabesch M; Roos D; Griese M; Hartl D
    J Immunol; 2008 Aug; 181(4):2753-63. PubMed ID: 18684966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Selective inhibition of phagocytic activity of rabbit alveolar macrophages by cystic fibrosis serum.
    Biggar WD; Holmes B; Good RA
    Am Rev Respir Dis; 1974 Mar; 109(3):403. PubMed ID: 4205434
    [No Abstract]   [Full Text] [Related]  

  • 12. Opsonic defect in patients with cystic fibrosis of the pancreas.
    Biggar WD; Holmes B; Good RA
    Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1716-9. PubMed ID: 5001942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsonin-independent phagocytosis of surface-adherent bacteria by human alveolar macrophages.
    Lee DA; Hoidal JR; Garlich DJ; Clawson CC; Quie PG; Peterson PK
    J Leukoc Biol; 1984 Dec; 36(6):689-701. PubMed ID: 6438262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of phagocytic activity of rabbit alveolar macrophages by cystic fibrosis serum.
    Boxerbaum B; Kagumba A; Matthews LW
    Am Rev Respir Dis; 1973 Oct; 108(4):777-83. PubMed ID: 4200425
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripheral decrease and pulmonary homing of CD4+CD45RO+ helper memory T cells in cystic fibrosis.
    Häusler M; Schweizer K; Biesterfel S; Opladen T; Heimann G
    Respir Med; 2002 Feb; 96(2):87-94. PubMed ID: 11860174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alveolar macrophage phagocytic kinetics following pulmonary parainfluenza-3 virus infection.
    Slauson DO; Lay JC; Castleman WL; Neilsen NR
    J Leukoc Biol; 1987 May; 41(5):412-20. PubMed ID: 3033112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa.
    Speert DP; Wong SY; Macdonald M; Sargeant R
    Behring Inst Mitt; 1997 Feb; (98):274-82. PubMed ID: 9382751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Phagocytosis of Blood Leukocytes from Cystic Fibrosis Patients is not Impaired in General.
    Leuer L; Krill A; Wilkens H; Wagenpfeil G; Bischoff M; Meier C; Bals R; Tschernig T
    Lung; 2020 Feb; 198(1):235-239. PubMed ID: 31707460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of leukocytic interferon on the functional state of bronchoalveolar phagocytes in lung diseases].
    Chernushenko EF; Belianovskaia TI; Kuznetsova LV; Shpak OI; Shatrov VA
    Ter Arkh; 1986; 58(4):83-5. PubMed ID: 3715762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemiluminescence measurement of phagocytic activity of pulmonary macrophages in sarcoid alveolitis.
    Saltini C; Brugni N; Magnani C; Capitolo S; Capelli O; Velluti G; Bisetti A
    Respiration; 1984; 45(3):291-5. PubMed ID: 6463392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.